A

AFT Pharmaceuticals Ltd
NZX:AFT

Watchlist Manager
AFT Pharmaceuticals Ltd
NZX:AFT
Watchlist
Price: 2.85 NZD 1.42% Market Closed
Market Cap: 298.9m NZD

Wall Street
Price Targets

AFT Price Targets Summary
AFT Pharmaceuticals Ltd

Wall Street analysts forecast AFT stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for AFT is 3.85 NZD with a low forecast of 3.13 NZD and a high forecast of 4.67 NZD.

Lowest
Price Target
3.13 NZD
10% Upside
Average
Price Target
3.85 NZD
35% Upside
Highest
Price Target
4.67 NZD
64% Upside
AFT Pharmaceuticals Ltd Competitors:
Price Targets
600521
Zhejiang Huahai Pharmaceutical Co Ltd
9% Upside
PBH
Prestige Consumer Healthcare Inc
7% Upside
CRON
Cronos Group Inc
35% Upside
002653
Haisco Pharmaceutical Group Co Ltd
3% Upside
4506
Sumitomo Pharma Co Ltd
12% Downside
600535
Tasly Pharmaceutical Group Co Ltd
1% Upside
VENUSREM
Venus Remedies Ltd
6% Downside
TORNTPHARM
Torrent Pharmaceuticals Ltd
13% Upside

Revenue
Forecast

Revenue Estimate
AFT Pharmaceuticals Ltd

For the last 8 years the compound annual growth rate for AFT Pharmaceuticals Ltd's revenue is 15%. The projected CAGR for the next 3 years is 15%.

15%
Past Growth
15%
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Operating Income
Forecast

Operating Income Estimate
AFT Pharmaceuticals Ltd

The compound annual growth rate of AFT Pharmaceuticals Ltd's operating income for the next 3 years is 16%.

N/A
Past Growth
16%
Estimated Growth
Estimates Accuracy
4%
Average Beat

Net Income
Forecast

Net Income Estimate
AFT Pharmaceuticals Ltd

The compound annual growth rate of AFT Pharmaceuticals Ltd's net income for the next 3 years is 14%.

N/A
Past Growth
14%
Estimated Growth
Estimates Accuracy
7%
Average Beat
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is AFT's stock price target?
Price Target
3.85 NZD

According to Wall Street analysts, the average 1-year price target for AFT is 3.85 NZD with a low forecast of 3.13 NZD and a high forecast of 4.67 NZD.

What is AFT Pharmaceuticals Ltd's Revenue forecast?
Projected CAGR
15%

For the last 8 years the compound annual growth rate for AFT Pharmaceuticals Ltd's revenue is 15%. The projected CAGR for the next 3 years is 15%.

What is AFT Pharmaceuticals Ltd's Operating Income forecast?
Projected CAGR
16%

The compound annual growth rate of AFT Pharmaceuticals Ltd's operating income for the next 3 years is 16%.

What is AFT Pharmaceuticals Ltd's Net Income forecast?
Projected CAGR
14%

The compound annual growth rate of AFT Pharmaceuticals Ltd's net income for the next 3 years is 14%.

Back to Top